COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
01.08.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!